Author

F. Chau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 2 Approach:experimental assay· 2 Assay:whole-genome sequencing· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

E. Denamur· 2 shared A. Bridier-Nahmias· 1 shared A. Moumouni· 1 shared A. Pourbaix· 1 shared A.-L. Page· 1 shared B. Assao· 1 shared B. Condamine· 1 shared B. Lacombe· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

E. Denamur

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Faecal carriage of ESBL-producing Escherichia coli in a remote region of Niger

H. Jacquier, B. Assao, F. Chau, O. Guindo, B. Condamine, M. Magnan, A. Bridier-Nahmias, N. Sayingoza-Makombe, A. Moumouni, A.-L. Page, C. Langendorf, M. Coldiron, E. Denamur, V. de Lastours

The paper uses whole genome sequencing to analyze ESBL-E. coli carriage in rural Niger, finding high prevalence of CTX-M-15 with chromosomal and plasmid integration.

bioRxiv · Jul 7, 2022 · PreprintMicrobiology

Chlorhexidine reduced susceptibility associated to tetracycline resistance in clinical isolates of Escherichia coli

G. ROYER, J.-M. Ortiz de la Rosa, X. Vuillemin, B. Lacombe, F. Chau, O. Clermont, M. Mercier-Darty, J.-W. Decousser, J.-D. Ricard, P. Nordmann, E. Denamur, L. Poirel

The paper identifies two distinct mechanisms of chlorhexidine resistance in E. coli: mlaA mutations in vitro and tetA efflux pumps in clinical isolates.

bioRxiv · Oct 5, 2021 · PreprintMicrobiology

Unexpected activity of oral fosfomycin against resistant strains of Escherichia coli in murine pyelonephritis.

A. Pourbaix, F. Guerin, C. Burdet, L. Massias, F. Chau, V. Cattoir, B. R. Fantin

This study shows fosfomycin effectively reduces bacterial loads in murine pyelonephritis, even against resistant strains, due to high local concentrations and altered physiological conditions.

bioRxiv · May 5, 2019Microbiology